BRIEF published on 05/23/2024 at 09:17, 1 year 8 months ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 8 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 1 year 9 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
BRIEF published on 04/25/2024 at 07:26, 1 year 9 months ago Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024 Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
PRESS RELEASE published on 04/25/2024 at 07:21, 1 year 9 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 1 year 9 months ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
BRIEF published on 04/05/2024 at 09:35, 1 year 9 months ago Heidelberg Pharma organisera un webinaire R&D pour partager de nouvelles informations sur la recherche sur le cancer Heidelberg Pharma HDP-101 Myélome Multiple ADC Webinaire R&D
PRESS RELEASE published on 04/05/2024 at 09:30, 1 year 9 months ago Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
BRIEF published on 03/27/2024 at 09:06, 1 year 10 months ago Heidelberg Pharma Obtains FDA Orphan Drug Designation for HDP-101 in Multiple Myeloma Treatment FDA Orphan Drug Designation Heidelberg Pharma HDP-101 Multiple Myeloma
BRIEF published on 03/27/2024 at 09:06, 1 year 10 months ago Heidelberg Pharma obtient la désignation de médicament orphelin par la FDA pour le HDP-101 dans le traitement du myélome multiple FDA Heidelberg Pharma Désignation De Médicament Orphelin HDP-101 Myélome Multiple
Published on 01/31/2026 at 03:15, 1 day 4 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 6 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 8 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 16 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 19 hours 29 minutes ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 5 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 9 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 11 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 13 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 14 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 14 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 23 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
